(EMAILWIRE.COM, August 14, 2018 ) The global urology surgical instruments market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, growing at a CAGR of 8.2%.

On basis of type, urology endoscopes market is segmented into laparoscopes, ureteroscopes, nephroscopes, resectoscopes, and cystoscopes. The laparoscopes segment is expected to hold the largest share of this market,in 2016. The large share of this segment can be attributed to the laparoscopic surgeries being less invasive, low risk of surgical site infection (SSI), technological advancements, and these surgeries are expected to cost less than the open cholecystectomies in the long run. However, the cystoscopes segment is expected to grow at the highest CAGR during forecast period.

Know More: https://www.marketsandmarkets.com/pdfdownload.asp?id=120080018

On the basis of type, endovision systems market is further categorized into endoscopic light sources, endoscopic cameras, wireless monitors and displays, and camera heads. The endoscopic light sources segment is expected to hold the largest share. The large share of the segment can be attributed to use of ecofriendly and cost-saving LED light sources, and technological advancements. However, endoscopic cameras segment is expected to grow at the highest CAGR during the forecast period.

On the basis of type, the peripheral instruments market is further segmented into insufflators and endoscopy fluid management systems. The insufflators segment is expected to hold the largest share and grow at the highest CAGR during the forecast period . This large share and high growth can be attributed to the growing number of laparoscopic procedures and technological advancements.

By product, the market is categorized into urology endoscopes, endovision systems, peripheral instruments, and consumables and accessories. The consumables and accessories segment is expected to command the largest share of the global urology surgical instruments market, by product, in 2016, and is also expected to grow at the highest CAGR during the forecast period (2016-2021). The large share and high growth of this segment can be attributed to factors such as increasing surgical intervention for urology conditions, advancements in minimally invasive surgeries, increasing prevalence of chronic kidney disorders that can lead to increase in kidney transplants, increase in awareness of urology conditions at early stages, and rising geriatric population.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=120080018